Navigation Links
Vestara and MedClean Technologies Announce Co-Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management
Date:9/21/2009

Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste. Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Irvine, CA (PRWEB) September 21, 2009 -- Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste.

Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Vestara's EcoRex® Automated Pharmaceutical Waste Management System utilizes barcode technology already widely used in hospitals to track drug utilization that prevents medication errors and a proprietary, continuously updated database of more than 180,000 National Drug Code (NDC) products, to instantly categorize pharmaceutical waste at time of presentation. By automating the identification and sorting of different types of residual drugs, empty containers, and each hospital's unique admixtures, EcoRex® eliminates the human error and potential cross contamination inherent in manual sorting of pharmaceutical waste to reduce negative impact on the environment. Just as important, relevant data and an audit trail are provided in the form of comprehensive reports for client records.

MedClean® Series Systems enable hospitals and other medical facilities to treat and dispose of their RMW stream and provide HIPAA-compliant destruction of confidential documents in an efficient, compliant, safe and cost-effective manner. MedClean provides a state-of-the-art on-site treatment solution for each end user through its full line of On-Demand Container, Mobile and in-house, fixed systems. MedClean's solutions provide significant advantages for hospital customers compared to other approaches, including lower costs, reduced risk and protection of host communities and the overall environment. A single MedClean Container system can treat 1 million pounds of RMW per year, in addition to handling confidential document destruction, with a smaller footprint required compared to multiple vendors handling different tasks for a hospital.

Working together, Vestara and MedClean bring unique technologies to a common customer base, addressing the toughest waste mitigation issues facing hospitals today.

Please visit booth # 419 at the 2009 ASHES Conference in Reno, NV, September 21-22, 2009, to learn more about the Vestara-MedClean Technologies partnership.

About Vestara
Vestara, headquartered in Irvine, CA, provides proprietary technology to automatically identify, sort, and segregate hazardous and non-hazardous pharmaceutical waste into proper waste streams. Vestara's solutions not only assure clients will be compliant with all federal and state laws, but that they will experience a more efficient health system workforce and true cost savings in managing pharmaceutical waste. Most importantly, clients will play a critical role in preserving our precious environment. To learn more, visit www.vestara.com.

About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

# # #

Read the full story at http://www.prweb.com/releases/2009/09/prweb2870584.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vestara Announces Agreement with Leading Environmental "Champion for Change" Company Amerinet
2. MedClean Technologies Inc. Announces New Ticker Symbol
3. MedClean Technologies Inc. CEO Publishes Letter to Shareholders
4. MedClean Technologies, Inc. Announces $1 Million Order
5. MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract
6. MedClean Technologies, Inc. Approved in New Jersey
7. MedClean Technologies Announces Results of Private Exchange Offer
8. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
9. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
10. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
11. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology: